Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Raymond James Downgrades DCP Midstream to Market Perform

Raymond James Downgrades DCP Midstream to Market Perform

Raymond James analyst Justin Jenkins downgrades DCP Midstream (NYSE:DCP) from Strong Buy to Market Perform.

byBenzinga Newsdesk

January 9, 2023

1 minute read

Raymond James analyst Justin Jenkins downgrades DCP Midstream (NYSE:DCP) from Strong Buy to Market Perform.

Analyst Ratings

What 4 Analyst Ratings Have To Say About Brixmor Property Group

By Benzinga Insights

December 1, 9:00 AM

Brixmor Property Group (NYSE:BRX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent…

BRX

$1000 Invested In This Stock 20 Years Ago Would Be Worth $6,100 Today

By Benzinga Insights

April 26, 10:00 AM

Automatic Data Processing (NASDAQ:ADP) has outperformed the market over the past 20 years by 1.85% on an annualized…

ADP

Why Home Improvement Retailer Home Depot’s Shares Are Shooting Higher Today

By Shivani Kumaresan

November 14, 11:29 AM

Home improvement retailer Home Depot Inc (NYSE: HD) reported a FY23 sales decline of 3% year-on-year to $37.71 billion,

BioCardia Presents Positive CardiAMP Cell Therapy Heart Failure Trial Two-Year Data At HFSA Annual Meeting

By Benzinga Newsdesk

October 3, 7:01 AM

BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces data from its FDA designated Breakthrough

BCDA

Raymond James Downgrades DCP Midstream to Market Perform

Related Posts

What 4 Analyst Ratings Have To Say About Brixmor Property Group

$1000 Invested In This Stock 20 Years Ago Would Be Worth $6,100 Today

Why Home Improvement Retailer Home Depot’s Shares Are Shooting Higher Today

BioCardia Presents Positive CardiAMP Cell Therapy Heart Failure Trial Two-Year Data At HFSA Annual Meeting